Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 289 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Development of a deep learning algorithm for Paneth cell density quantification for inflammatory bowel disease.
Kang LI, Sarullo K, Marsh JN, Lu L, Khonde P, Ma C, Haritunians T, Mujukian A, Mengesha E, McGovern DPB, Stappenbeck TS, Swamidass SJ, Liu TC
EBioMedicine, 110:105440, 12 Nov 2024
Cited by: 0 articles | PMID: 39536395
Add to export list
Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction.
Sun S, Hodel M, Wang X, De Vicente J, Haritunians T, Debebe A, Hung CT, Ma C, Malique A, Nguyen HN, Agam M, Maloney MT, Goo MS, Kluss JH, Mishra R, Frein J, Foster A, Ballentine S, Pandey U, [...] Liu TC
Sci Immunol, 9(101):eadi7907, 08 Nov 2024
Cited by: 0 articles | PMID: 39514635
Add to export list
A Proteomics Pipeline for Generating Clinical Grade Biomarker Candidates from Data-Independent Acquisition Mass Spectrometry (DIA-MS) Discovery.
Fu Q, Vegesna M, Sundararaman N, Damoc E, Arrey TN, Pashkova A, Mengesha E, Debbas P, Joung S, Li D, Cheng S, Braun J, McGovern DPB, Murray CI, Xuan Y, Van Eyk JE
Angew Chem Int Ed Engl, e202409446, 21 Oct 2024
Cited by: 1 article | PMID: 39432331
Add to export list
The JAK inhibitor, Tofacitinib, Corrects the Overexpression of CEACAM6 and Limits Susceptibility to AIEC Caused by Reduced Activity of the IBD Associated Gene,PTPN2
Chatterjee P, Canale V, King SJ, Shawki A, Lei H, Haddad M, Gries CM, McGovern DP, Borneman J, McCole DF
medRxiv, 28 Sep 2024
Cited by: 0 articles | PPR: PPR916799
Add to export list Preprint
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, Rubin DT, Laurent O, Luo A, Nguyen DD, Lu J, Yen M, Leszczyszyn J, Kempiński R, McGovern DPB, Ma C, Ritter TE, Targan S, ARTEMIS-UC Study Group
N Engl J Med, 391(12):1119-1129, 01 Sep 2024
Cited by: 0 articles | PMID: 39321363
Add to export list
Immunohistochemistry annotations enhance AI identification of lymphocytes and neutrophils in digitized H&E slides from inflammatory bowel disease.
Zurek N, Zhang Y, McGovern DPB, Walts AE, Gertych A
Comput Methods Programs Biomed, 257:108423, 13 Sep 2024
Cited by: 0 articles | PMID: 39306985
Add to export list
Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease.
Ioannou S, Beecham A, Gomez L, Dauer R, Khakoo N, Pascual L, Quintero M, Lopez J, Leavitt JS, Solis N, Ortega M, Deshpande AR, Kerman DH, Proksell S, Torres EA, Haritunians T, Li D, Abreu MT, McGovern DPB, [...] Damas OM
Clin Gastroenterol Hepatol, S1542-3565(24)00766-3, 23 Aug 2024
Cited by: 0 articles | PMID: 39181428
Add to export list
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
Lee YJ, Li D, Mujukian A, Debbas P, Hampton M, Mengesha E, Cheng S, Ebinger JE, Chiorean M, Lum D, Damas OM, Braun J, McGovern DPB, Melmed GY, CORALE-IBD Study Group
Inflamm Bowel Dis, 30(8):1430-1434, 01 Aug 2024
Cited by: 0 articles | PMID: 37773982 | PMCID: PMC11291623
Add to export list Free full text in Europe PMC
Artificial Intelligence- and Physician-Interpreted Stool Image Characteristics Correlate With C-Reactive Protein Among Inpatients With Acute Severe Ulcerative Colitis: A Pilot Study.
Rotondo-Trivette S, Castelan VC, Mathur K, Yasmeh P, Kraus A, Lynch A, McGovern DPB, Melmed GY
Crohns Colitis 360, 6(3):otae043, 01 Jul 2024
Cited by: 0 articles | PMID: 39206451 | PMCID: PMC11350077
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.
McGovern DP, McClure ME, Coates M, Bond S, Martinez Del Pero M, Mynard K, Lee J, Smith RM, Jayne DR, Clatworthy MR, Jones RB, ObiVas Investigators
BMJ Open, 14(7):e083277, 17 Jul 2024
Cited by: 0 articles | PMID: 39019638 | PMCID: PMC11256062
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
After Surgically Induced Remission, Ileal and Colonic Mucosa-Associated Microbiota Predicts Crohn's Disease Recurrence.
Hernández-Rocha C, Turpin W, Borowski K, Stempak JM, Sabic K, Gettler K, Tastad C, Chasteau C, Korie U, Hanna M, Khan A, Mengesha E, Bitton A, Schwartz MB, Barrie A, Datta LW, Lazarev M, Brant SR, Rioux JD, [...] Silverberg MS
Clin Gastroenterol Hepatol, S1542-3565(24)00592-5, 04 Jul 2024
Cited by: 1 article | PMID: 38969076
Add to export list
Ileal Paneth Cell Phenotype is a Cellular Biomarker for Pouch Complications in Ulcerative Colitis.
Ma C, Haritunians T, Gremida AK, Syal G, Shah J, Yang S, Ramos Del Aguila de Rivers C, Storer CE, Chen L, Mengesha E, Mujukian A, Hanna M, Fleshner P, Binion DG, VanDussen KL, Stappenbeck TS, Head RD, Ciorba MA, McGovern DPB, Liu TC
J Crohns Colitis, jjae105, 02 Jul 2024
Cited by: 0 articles | PMID: 38953127
Add to export list
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus.
Wong SY, Rowan C, Brockmans ED, Law CCY, Giselbrecht E, Ang C, Khaitov S, Sachar D, Polydorides AD, Winata LS, Verstockt B, Spinelli A, Rubin DT, Deepak P, McGovern DPB, McDonald BD, Lung P, Lundby L, Lightner AL, [...] Colombel JF
Clin Gastroenterol Hepatol, S1542-3565(24)00504-4, 12 Jun 2024
Cited by: 0 articles | PMID: 38871152
Add to export list Review
Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients.
Kennedy AM, Griffiths AM, Muise AM, Walters TD, Ricciuto A, Huynh HQ, Wine E, Jacobson K, Lawrence S, Carman N, Mack DR, deBruyn JC, Otley AR, Deslandres C, El-Matary W, Zachos M, Benchimol EI, Critch J, Schneider R, [...] Cohn I
Inflamm Bowel Dis, izae109, 24 May 2024
Cited by: 0 articles | PMID: 38788739
Add to export list
Prior probability cues bias sensory encoding with increasing task exposure.
Walsh K, McGovern DP, Dully J, Kelly SP, O'Connell RG
Elife, 12:RP91135, 02 Apr 2024
Cited by: 1 article | PMID: 38564237 | PMCID: PMC10987094
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn's Disease.
Hernández-Rocha C, Walshe M, Birch S, Sabic K, Korie U, Chasteau C, Miladinova VM, Sabol WB, Mengesha E, Hanna M, Pozdnyakova V, Datta L, Kohen R, Milgrom R, Stempak JM, Bitton A, Brant SR, Rioux JD, McGovern DPB, [...] Lazarev M
J Crohns Colitis, 18(4):615-627, 01 Apr 2024
Cited by: 2 articles | PMID: 37976264 | PMCID: PMC11037109
Add to export list Free full text in Europe PMC
Paradigm shift in biomarker translation: a pipeline to generate clinical grade biomarker candidates from DIA-MS discovery
Fu Q, Vegesna M, Sundararaman N, Damoc E, Arrey TN, Pashkova A, Mengesha E, Debbas P, Joung S, Li D, Cheng S, Braun J, McGovern DP, Murray C, Xuan Y, Eyk JEV
bioRxiv, 22 Mar 2024
Cited by: 0 articles | PPR: PPR826565
Add to export list Preprint
Radiomics-Based Analysis of Intestinal Ultrasound Images for Inflammatory Bowel Disease: A Feasibility Study.
Gu P, Chang JH, Carter D, McGovern DPB, Moore J, Wang P, Huang X
Crohns Colitis 360, 6(2):otae034, 01 Apr 2024
Cited by: 1 article | PMID: 38903657 | PMCID: PMC11187771
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease.
Gu P, Dube S, Gellada N, Choi SY, Win S, Lee YJ, Yang S, Haritunians T, Melmed GY, Vasiliauskas EA, Bonthala N, Syal G, Yarur AJ, Ziring D, Rabizadeh S, Fleshner P, Kallman C, Devkota S, Targan SR, [...] McGovern DP
World J Gastrointest Surg, 16(3):740-750, 01 Mar 2024
Cited by: 0 articles | PMID: 38577075 | PMCID: PMC10989343
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Spencer EA, Dubinsky MC, Kamm MA, Chaparro M, Gionchetti P, Rizzello F, Gisbert JP, Wright EK, Schulberg JD, Hamilton AL, McGovern DPB, Dervieux T
Front Immunol, 15:1383704, 27 Feb 2024
Cited by: 0 articles | PMID: 38476224 | PMCID: PMC10929709
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Khrom M, Long M, Dube S, Robbins L, Botwin GJ, Yang S, Mengesha E, Li D, Naito T, Bonthala NN, Ha C, Melmed G, Rabizadeh S, Syal G, Vasiliauskas E, Ziring D, Brant SR, Cho J, Duerr RH, [...] McGovern DPB
Gastroenterology, 167(2):315-332, 13 Mar 2024
Cited by: 3 articles | PMID: 38490347
Add to export list
AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD.
Gu P, Mendonca O, Carter D, Dube S, Wang P, Huang X, Li D, Moore JH, McGovern DPB
Inflamm Bowel Dis, izae030, 07 Mar 2024
Cited by: 2 articles | PMID: 38452040
Add to export list
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Spencer EA, Dubinsky MC, Kamm MA, Chaparro M, Gionchetti P, Rizzello F, Gisbert JP, Wright EK, Schulberg JD, Hamilton AL, McGovern DPB, Dervieux T
Front Immunol, 15:1342477, 23 Jan 2024
Cited by: 0 articles | PMID: 38476237 | PMCID: PMC10929708
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Promoting equity in inflammatory bowel disease: a global approach to care.
Sebastian S, Siegmund B, Teferra F, McGovern DPB, Queiroz NSF, van der Woude CJ, Sharma V
Lancet Gastroenterol Hepatol, 9(3):192-194, 11 Jan 2024
Cited by: 1 article | PMID: 38219765
Add to export list
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease.
McDonald GB, Landsverk OJB, McGovern DPB, Aasebø A, Paulsen V, Haritunians T, Reims HM, McLaughlin BM, Zisman T, Li D, Elholm ETMM, Jahnsen FL, Georges GE, Gedde-Dahl T
Heliyon, 10(1):e24026, 03 Jan 2024
Cited by: 0 articles | PMID: 38283244 | PMCID: PMC10818189
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 289 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Development of a deep learning algorithm for Paneth cell density quantification for inflammatory bowel disease.

Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction.

A Proteomics Pipeline for Generating Clinical Grade Biomarker Candidates from Data-Independent Acquisition Mass Spectrometry (DIA-MS) Discovery.

The JAK inhibitor, Tofacitinib, Corrects the Overexpression of CEACAM6 and Limits Susceptibility to AIEC Caused by Reduced Activity of the IBD Associated Gene,PTPN2

Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.

Immunohistochemistry annotations enhance AI identification of lymphocytes and neutrophils in digitized H&E slides from inflammatory bowel disease.

Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease.

Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.

Artificial Intelligence- and Physician-Interpreted Stool Image Characteristics Correlate With C-Reactive Protein Among Inpatients With Acute Severe Ulcerative Colitis: A Pilot Study.

Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.

After Surgically Induced Remission, Ileal and Colonic Mucosa-Associated Microbiota Predicts Crohn's Disease Recurrence.

Ileal Paneth Cell Phenotype is a Cellular Biomarker for Pouch Complications in Ulcerative Colitis.

Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus.

Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients.

Prior probability cues bias sensory encoding with increasing task exposure.

Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn's Disease.

Paradigm shift in biomarker translation: a pipeline to generate clinical grade biomarker candidates from DIA-MS discovery

Radiomics-Based Analysis of Intestinal Ultrasound Images for Inflammatory Bowel Disease: A Feasibility Study.

Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease.

Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.

Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.

AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD.

Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.

Promoting equity in inflammatory bowel disease: a global approach to care.

Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease.

Partnerships & funding